retatrutide phase 2 diabetes trial type 2 results 2024 ada demonstrate benefits of in obesity, diabetes, NASH Efficacy and Safety of Retatrutide – Effects of retatrutide on body

Ratiometric NAD + sensors reveal subcellular NAD + modulators

Management of calcific coronary artery lesions: is it time to change our interventional therapeutic approach

This disconnect between the idea of expanding scope of practice and how it actually plays out in the real world is one of the reasons that patients should still be diligent about whos treating them

For an injectable biologic, competition from biosimilars produces a slope rather than a cliff a gradual erosion over years rather than months

This process, followed by the conversion of these bile acids into deoxycholic acid and lithocholic acid by the gut microbiota, can lead to a reduction in microbial diversity and the occurrence of gut dysbiosis